Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis

Objective : To evaluate the cost effectiveness of etoricoxib (90mg/day) relative to celecoxib (200 or 400mg/day), and the non-selective NSAIDs naproxen (1000mg/day) and diclofenac (150 mg/day) in the initial treatment of ankylosing spondylitis (AS) from the UK NHS perspective. Methods : A Bayesian c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PharmacoEconomics 2010-01, Vol.28 (4), p.323-344
Hauptverfasser:	Jansen, Jeroen P., Gaugris, Sabine, Choy, Ernest H., Ostor, Andrew, Nash, Julian T., Stam, Wiro
Format:	Artikel
Sprache:	eng
Schlagworte:	Ankylosing spondylitis Anti-Inflammatory Agents, Non-Steroidal - economics Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Arthritis Bayes Theorem Celecoxib Comparative analysis Cost analysis Cost-Benefit Analysis Cost-effectiveness Cost-utility Cyclooxygenase 2 Inhibitors - economics Cyclooxygenase 2 Inhibitors - therapeutic use Diclofenac Diclofenac - economics Diclofenac - therapeutic use Dosage and administration Drug Costs Drug therapy Drug-Related Side Effects and Adverse Reactions - economics Economic aspects Economic theory Etoricoxib Health Administration Health Economics Health technology assessment Humans Intervention Markov Chains Mathematical analysis Medical care, Cost of Medical research Medicine Medicine & Public Health Meta-Analysis as Topic Models, Economic Naproxen Naproxen - economics Naproxen - therapeutic use Nonsteroidal anti-inflammatory drugs Nonsteroidal-anti-inflammatories Original Research Article Osteoarthritis Parameter estimation Patients Pharmaceuticals Pharmacoeconomics and Health Outcomes Public Health Pyrazoles - economics Pyrazoles - therapeutic use Pyridines - economics Pyridines - therapeutic use Quality of Life Research Quality-Adjusted Life Years Severity of Illness Index Spondylitis, Ankylosing - drug therapy Spondylitis, Ankylosing - economics Studies Sulfonamides - economics Sulfonamides - therapeutic use Sulfones - economics Sulfones - therapeutic use Systematic review therapeutic use treatment Treatment Outcome Tumor necrosis factor-TNF United Kingdom
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!